OTUD6B and hepatocellular carcinoma: In contrast, in hepatocellular carcinoma (HCC), OTUD6B-AS1 could enhance cell proliferation and invasion ability via the GSKIP/Wnt/β-catenin signaling pathway (Kong et al., 2020).